chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sitting in chair, tipped to side after receiving 3 vaccines, fainted against a table. Staff moved him to the floor and used ammonia capsule to rouse.  Roused easily. No injury incurred. Vitals stable at 15 minute check. Departed with parent.
Chest pain, tightness while walking on April 22.  Subsided after about an hour.  Again on April 24 while walking, subsided after about an hour.  April 26, woke up around 4am with chest pain.  Called 911 and went to emergency room.  EKG and triponin negative for heart attack.  Discharged and told to follow up with family doctor when I return home. April 27 saw family doctor.  EKG taken and no concerns.  Referred to cardiologist. May 12 saw cardiologist.  Said all symptons describe a cardiac event but I don't fit the profile.  No family history, healthy and fit.  May 21, CT scan of heart.  Results showed no blockages of any kind.
Loss of appetite and fatigue beginning on approximately 3/6 (reports maybe sooner) then began breaking out with a chicken pox rash on back and side of neck, torso, both thighs.
Somnolence, crying nonstop for 3 days, loss of appetite/inability to nurse, diarrhea and continuing gut issues from then on, no weight gain.
My arm where I got the injection became VERY swollen, it honestly looked like a softball was in my arm. It also was painful, red, and rashy. For about three days following the shot I exp were winced fatigue and headaches.
No major side effects with FIRST dose, only sore arm at injection site for about 12 hours. Second dose has resulted in severe swelling at injection site. Pain was comparable to the first dose until about 12 hours later. Before bed I took one standard strength ibuprofen and drank plenty of fluids, with more at my nightstand. Woke up several times throughout the night due to arm pain. The following morning woke up with severe arm pain and swelling, nausea, fatigue, extreme thirst, and chills. No fever. Shoulder region at injection site was red and warm to the touch, with the swollen region about 3.5 inches in diameter. Arm pain continues but is not hindering movement or normal activities. Swollen region has not decreased in size and remains red, warm to touch.
Fever developed the next day after the vaccine. Pt also developed diarrhea, rhinitis and high-pitched scream, and increased anger and aggressiveness after the immunizations. She had a temperature of 99.8 at home after taking 1-2 doses of ibuprofen per day. 1 week later she had increased sneezing.
This spontaneous report was received from a nurse via a company representative and refers to a 3 years 10 months old male patient. No information regarding the patient's concurrent condition, medical history, concomitant medications and drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a first dose of VARIVAX (exact dose, route of administration, lot number and expiration date were not reported) for prophylaxis. In October 2018, the patient experienced ophthalmic shingles. He sought medical attention. Blood work was performed in October 2018 and the patient had a positive titer for varicella-zoster virus. The patient was prescribed unspecified antivirals to treat the event. The patient was scheduled to follow up with an unspecified dermatologist and an unspecified ophthalmologist on unspecified dates. The outcome of ophthalmic shingles was reported as recovering. The patient still had itching on the eye. The relatedness between ophthalmic shingles and VARIVAX was not reported. Upon internal review, the ophthalmic shingles was determined to be medically significant.
Mom called triage line 11/5/18 @ 1546. Mom reported on 11/1/8 redness and hard spot noted to thigh. Daughter C/O pain and refused to walk on leg. Daughter had emesis x 1. Daughter seemed fussier than usual. Mom considered bringing in child for assessment, but did not due to her schedule. Redness, hard spot, pain no longer present.
flu symptoms; muscle spasm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 05Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INFLUENZA (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "flu symptoms"; MUSCLE SPASMS (non-serious) with onset Mar2021, outcome "unknown", described as "muscle spasm". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous consumer report (initial receipt 17-SEP-2014) concerns a 58-year-old female patient. On 15-SEP-2014, the patient received intramuscular AFLURIA (batch number not provided) at 0.5 ml. On 15-SEP-2014, approximately four hours after AFLURIA pre-filled syringe  administration, the patient experienced flu-like symptoms which included congestion, burning and feverish eyes, heavy fatigue and achy joints. The outcome was reported as recovered on 17-SEP-201. Reporter's comments: The reporter assessed the events as non-serious.
Information has been received from a physician concerning a 15 year old white female with no illness at time of vaccination, who on 22-AUG-2007 was vaccinated intramuscularly in the right deltoid muscle with a 0.5 ml dose of GARDASIL and concomitantly vaccinated on the same day with a dose of MENACTRA at separate injection sites. On 24-AUG-2007, post vaccination, the patient experienced intermittent bouts/episodes (1/day to 3/week) of vomiting, nausea and diarrhea which resulted in the patient missing school. Per the reporting physician, symptoms persisted for approximately 6 weeks. The patient received unspecified medical attention. Per the doctor, at the time of this report it is unknown if the patient had recovered. Reporting physician did not associate patient's illness with vaccine. On 24-SEP-2007, laboratory evaluations revealed comprehensive panel within normal limits and serum thyroid stimulating hormone 1.72. Complete blood count revealed white blood cell count was 6.7 1000/mm3, red distribution with 12.3 (L) and monocytes 7% (H). No additional information expected
headache; chest tightness and cough.  Albuterol for Rx.  Started later same day  and still present;  No other allergic signs Tested subequently for COVID 19 by PCR and negative
I received coughing; fever; post nasal drip; and extra tired 3 weeks and I took Paxlovid
Nausea, low grade fever 24 hrs after vaccine. Vaccine given 5/22/14.
Body Aches, Headache, Ear ache, Chills, Minor fever.  Body aches became so bad that by 8PM I was totally bent over like a 100 year old.  Symptoms gone 24 hours later, but I was exhausted.
low grade fever 107; blood pressure 152/94 bpm 98; chills; weakness;  Primary care referred to the ER
Since my 2nd dose moderns I have had intermittent EXTREME fatigue. 2-4x month that is completely out of context with my usual behavior. My elder sibling is also experiencing same effects but more frequently. (Moderna) I wanted this vaccine but have never experienced this extreme fatigue. Disconcerning.
Morning of injection - itching; Evening of injection - swelling, redness, itching, palpable mass in deltoid about the size of a silver dollar; arm goes to sleep easily and hand pain exists.  Is still that way, although redness has faded somewhat.
Pt. voiced hx of difficulty breathing and rash after taking miralax.Pt states her PMD recommends she get CODID-19 vaccine,  Our medical director consulted and agreed to give with 30 min wait time, near onsite paramedics.  I  vaccinated pt. next to paramedic.  10 minutes later pt. c/o dizziness, SOB, trouble breathing .  Paramedics assumed care, Epi Pen administered. Ambulance called pt. soon felth better after O2 and Epi.  No LOC. Pt. left in ambulance talking and thankful.
Patient stated that "I feel funny. I feel shaky and my fingers are all tingly." Pt's vitals were taken and they were stable,  pt was observed for 30 more minuets and was educated on the signs and symptoms of  anaphylaxis and the symptoms happen. Upon discharge from the clinic, the pt stated that she was feeling better.
(R) arm pain. Decreased range of motion. Pain across chest and back. Throbbing pain down (R) arm into fingertips after injection. Stabbing pain - back-neck-chest.
Feel like , I have a cold or allergies, Lower back pain, Abdominal Pain One Knee was shaking right after vaccine  Full body pain daily mostly in the lower back
I got both Shingles vaccines and about 5 months later had an large and painful outbreak in the same place that reoccurs/suspected Vaccination failure; had an large and painful outbreak in the same place that reoccurs; painful outbreak; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and 5 months after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and pain. On an unknown date, the outcome of the vaccination failure, shingles and pain were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received both dose of Shingles vaccine and about 5 months later had a large and painful outbreak in the same place that reoccurs. This case was considered as suspected vaccination failure as detail regarding laboratory test confirming herpes zoster was unknown at the time of reporting.
A 11-year-old male patient was inadvertently immunized with Pfizer-BioNTech COVID-19 vaccine which is approved for 12 years-old and older.  Patient was observed for the recommended 15 minutes post-vaccination with no adverse events noted.
patient requested pfizer bivalent adult dose and pfizer monovalent was given. per cdc recommendations will come back in 2 months to get pfizer bivalent . no adverse outcomes reported by patient
Patient complained of muscle pain radiating to elbow and up towards neck about 2-3 weeks after receiving flu injection. No pain or swelling immediately after shot. Also complains of right arm weakness. Was given 12 day prednisone taper which helped, but symptoms returned.
Approximately 24 hours after receiving the Pfizer Covid vaccine, I experienced hot/cold chills, clammy face and lips.  I noted that I had pink/red allergic marks on both legs.  I mentioned it to the nurse today as I was receiving my 2nd dose and filled out report.
Pharmacist gave flu shot on 10/02/19.  As soon as shot was given patient felt pain all the way down arm. Never happened before to patient.  Patient stated it should not feel that way and Pharmacist  told her it was " because she was tense, & you will be fine". Pt. states unable to sleep from pain & worry & does not know yet of long term effects &/or damage to her body, concerned about unnecessary pain & suffering.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history and drug allergies reported. On 18-JUN-2015 the patients were vaccinated with improperly stored PROQUAD (Merck) (lot number L005297 and expiry date 17-AUG-2016) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The action taken with the therapy with PROQUAD (Merck) was unknown. The outcome of the events to the therapy with PROQUAD (Merck) was unknown. The relatedness of the events to the therapy with PROQUAD (Merck) was unknown. There was no product quality issue reported. This is one of the many reports from the same source. Additional information has been requested.
I got some red, blotchiness in different pars of my left forearm and left hand; They are anywhere quarter by quarter squares to pinpoint sized red dots; This is a spontaneous report from a contactable consumer (patient). A male patient of unspecified age received first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration Mar2021 at 1st dose, single dose for COVID-19 immunization and second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: unknown), via an unspecified route of administration on 01Apr2021 as 2nd dose, single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that he experienced some red, blotchiness in different parts of his left forearm and left hand and they are anywhere quarter by quarter squares to pinpoint sized red dots on an unspecified date. The patient stated that when he went to doctor he said it is from burst capillaries. But he didn't know what the cause of it was. The only thing they were coming up with is that is the arm he got the vaccine in. He had received both doses. Second dose was April 1st and the first dose was 3 weeks before that. The patient was still experiencing it. Some have faded away. But more have showed up. He noticed it about 2 1/2 weeks after his vaccine. His doctor kept him on prednisolone treatment. Therapeutic measures were taken as a result of event which included prednisone and that helped stop it a little bit and was concerning because if this is reaction he may be hard pressed to get a booster. The patient stated "I don't like what's going on because I don't know what's going on. If the CDC says I should get one every year, I wouldn't want to get a Pfizer because I don't know if that's what caused that. This is a little un-nerving because I was all in favor of these vaccines, but now I don't know. Is the reaction on my left arm connected to the vaccine?". The outcome of the events was reported as resolving.  Information about batch no/lot no has been requested.
Aches in spine and muscles; Aches in spine and muscles; Administration date: 29Oct2021, dose number=3; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF8841) via an unspecified route of administration in the left arm on 29Oct2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications taken for an unknown indication on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FR8733) via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 57-years-old) and also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 29Oct2021, the patient had "administration date 29Oct2021, dose number=3". On 30Oct2021, the patient had aches in spine and muscles. The events aches in spine and muscles did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events aches in spine and muscles. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events aches in spine and muscles was resolved on an unknown date in 2021. The clinical outcome of the event "administration date 29Oct2021, dose number=3" was unknown at the time of this report.
patient experienced symptoms of covid arm 1 week after receiving dose 1.  redness and itching on the arm lasted a few days then resolved
Autopsy pending. Autopsy rec'd 1031/2005 -- COD was SIDS w/cosleeping w/both parents.
Approx. 08/10/98 pt received Hepatitis A virus vaccine inactivated. Approx. 09/28/98 lab results revealed "high IgM & IgG levels. Reporting MD felt results not related to vax. Pt sought unspecified medical attention. Hyperimmunoglobulinemia
Patient called pharmacy on 10/2/09 reporting bruising, swelling, redness, bumps, upset stomach and headache. Used TYLENOL and cold pack as of 10/8/09 patient stated most sx gone - still sore.
Within 1 day she felt body ache (typical), but within a few days she became weaker and weaker.  Within 1 week she could no longer walk.  She was admitted for 5 days due her inability to ambulate.  She continues to have weakness but now also orthostatic hypotension (previously she had hypertension--so all of her hypertension medications were stopped/changed since her symptoms are so profound--BP 68/32 at times!)
This prospective pregnancy case was reported by a consumer and described the occurrence of arm pain in a 37-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). A physician or other health care professional has not verified this report during pregnancy. The subject's medical history included one previous pregnancy that resulted in a normal birth complicated by gestational diabetes. Concurrent medications included Prenatal vitamin, Calcium + D and Fish oil. On 8 October 2012 the subject received unspecified dose of FLUARIX (unknown, left arm). Her last menstrual period was on 25 September 2012 and estimated date of delivery was 02 July 2013. This pregnancy was by in vitro fertilization. At the time of the report, no testing has been performed. The subject was exposed to FLUARIX at two weeks gestation, during the first trimester. On 8 October 2012, at the time of vaccination with FLUARIX, the subject experienced vaccine exposure during pregnancy. On 8 October 2012, 3 hours after vaccination with FLUARIX, the subject experienced arm pain. By mid day on 09 October 2012, the arm pain resolved. The outcome of the pregnancy was unknown. The subject considered the arm pain related to vaccination with FLUARIX.
pt arrived @ hosp unconscious & suffering trauma from multiple stab wounds;pt recv vax as part of wounds management & was adm to hosp;pt has remained unconscious & MD is classifying the lack of consciousness as encephalopathy;
This case was reported by a nurse via sales rep and described the occurrence of skin warm in a adult patient who received FLUARIX TETRA. Co-suspect products included FLULAVAL TETRA. On an unknown date, the patient received FLUARIX TETRA at an unknown dose and FLULAVAL TETRA at an unknown dose. On an unknown date, unknown after receiving FLUARIX TETRA and FLULAVAL TETRA, the patient experienced skin warm, local swelling and pain localized. On an unknown date, the outcome of the skin warm, local swelling and pain localized were unknown. It was unknown if the reporter considered the skin warm, local swelling and pain localized to be related to FLUARIX TETRA and FLULAVAL TETRA. Additional details were received as follows: The age at vaccination was not reported. It was reported that the sales representative was not sure if the patient received FLUARIX or FLALAVAL vaccine. The sales representative was not aware of which flu vaccine there was an adverse event associated with. The patient who was an employee had a local reaction to flu vaccine as hot to touch, swelling and soreness. The sales representative had no other information and stated that someone could reach out to the nurse to obtain more information on the adverse event. The sales representative would also like the event to be emailed to him if possible. This case has been linked with case US2017157939, reported by the same reporter.
Received first in a series of 2 injections for the Moderna COVID-19 vaccine on 12/30/2020. Headache, fatigue, joint pain  were noted for approximately after 24-72 hours and again on days 6 and 7 after injection, along with red circular rash at injection site that was about size of a quarter on right upper arm that became  apparent 24 hours after injection. Rash was also hot to the touch, and itchy.  Approximately on day 6 after injection, rash became raised, felt firm and spread in diameter to  approximately 3-3.5 inches, rash was raised and firm off and on for several days.  By day 12 after injection, rash was starting to lighten in color but was continuing to grow in size to approximately 5 inches in diameter, it was no longer raised or firm, but continued to be hot to the touch and itchy, even with daily use of oral Benadryl and Loratadine . Out of concern that it was not going away on its own contacted PCP on day 14 post vaccine and notified of  situation and office visit made on day 15 post vaccine on 1/14/21 for further assessment. PCP prescribed course of antibiotics (Bactrim x 10 days) as could not  determine if it was  truly infection or localized immune response, or combination of both. Was also prescribed  5 day course of steroids (prednisone) to take prior to and after next COVID vaccine injection.
It was minor but odd. I felt fine but about 4 or 5 days after the injection I got a rash at the injection site and itchy arm that lasted over a week.
Pt states she experienced excessive watery eyes with occasional blurred vision that started approx. 1 hour post vaccination and continued on and off for approx. 3 hours.  This has since resolved per pt account.
A 1/2 dollar sized, slightly raised, reddened area on left deltoid. 2 days later area looks less red, but bruised, slight thickening palpable in area 3 X 1.5 cm. Will continue to observe.
Patient reports swelling at injection site starting day after vaccination. Initial swelling resolved, but has moved to the forearm area. Patient reports no rash or fever. Advised patient to call PCP if increased swelling, fever develops, rash develops, or not impoved by Monday.
UNEXPECTED BENEFIT; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnicity.  The patient's height, and weight were not reported. The patient's concurrent condition included psoriasis. The patient was previously treated with Taltz (ixekizumab) for psoriasis.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: 21-SEP-2021) dose was not reported, dose number in series 01, administered on 02-APR-2021 for prophylactic vaccination in left arm. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced unexpected benefit. He reported his psoriasis improved and flare ups were halted. He did not have to take his Taltz medication (dose number series 1).   The action taken with covid-19 vaccine ad26.cov2.s was not applicable.  The outcome of unexpected benefit was not reported.  On 26-OCT-2021, the patient received second dose of covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822811, expiry date: unknown) dose was not reported for prophylactic vaccination in left arm (dose number series 2).   The patient had no problems following second dose of covid-19 vaccine ad26.cov2.s (dose number series 2).  This report was non-serious.